FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

FDAs Whole-of-Government Approach to Illicit Products

FDA officials say the agency is taking a whole-of-governments approach to combating the entry of illicit healthcare products into the U.S.

Medical Devices

FDA Clears Viz.ai Algorithm

FDA clears a Viz.ai algorithm to give the ratio between right and left ventricle diameters in a patients heart for use in pulmonary embolism treatment...

latest-news-card-1
Human Drugs

Former Pharmatech CEO Gets 37 Months in Jail

A Florida federal judge sentenced the former CEO of Pharmatech to 37 months in federal prison after he pled guilty to several charges of lying to and ...

latest-news-card-1
Human Drugs

Ascendis NDA for Hypoparathyroidism Therapy

Ascendis Pharma files an NDA for TransCon PTH, an investigational prodrug designed to restore parathyroid hormone (PTH [1-34]) to physiological levels...

latest-news-card-1
Federal Register

Ubrelvy Regulatory Review Period Determined

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Allergans Ubrelvy (ubrogepant), indicated for t...

latest-news-card-1
Federal Register

Regulatory Review Period for TherOx Downstream System

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for TherOxs PMA for the TherOx Downstream System, i...

latest-news-card-1
Biologics

FDA Authorizes Moderna, Pfizer-BioNTech Boosters

FDA authorizes Modernas and Pfizer-BioNTechs updated (bivalent) Covid-19 vaccines for use as a single booster dose at least two months following prima...

latest-news-card-1
Biologics

FDA Loses California Stem Cell Treatment Case

A California federal judge rejects FDA regulation of a stem cell clinic, saying it is engaged in the practice of medicine.

latest-news-card-1
Medical Devices

Novo Nordisk Pays $6.3 Million Over False Claims

Novo Nordisk agrees to pay $6.3 million to resolve allegations that it violated the False Claims Act by selling its NovoFine needles to U.S. governmen...

latest-news-card-1
Human Drugs

FDA OKs Genzymes Xenpozyme for ASMD

FDA approves Genzymes Xenpozyme to treat acid sphingomyelinase deficiency in children and adults.